Bausch Health Companies Inc. Common Stock (BHC)

FairStock Score: 61/100 — STEADY

Key Financials

Strengths

• Generates $1.1 billion in annual free cash flow (51.7% yield on market cap)
• High return on equity of 436.4% demonstrating efficient capital deployment
• Established organization with 20,300 employees providing operational scale

Concerns

• High leverage at 55.91x debt-to-equity increases financial risk and interest expense burden
• Currently unprofitable—sustained losses could lead to dilutive capital raises or balance sheet deterioration
• Altman Z-Score of -0.2 places it in the financial distress zone—elevated bankruptcy risk

AI Analysis

Bausch Health Companies Inc. Common Stock is a small-cap healthcare company valued at $2.1 billion. Revenue stands at $10.3 billion, though the company is currently unprofitable. From a quality standpoint, Bausch shows distressed Altman Z-Score of -0.2 warrants caution and extraordinary 436% return on equity. On valuation, the stock is attractively valued at 13.2x earnings, with strong 19.2% free cash flow yield. Growth dynamics show revenue growing at 9.3% and profit growth of -220.4%. Our composite FairStock Score of 61/100 reflects above-average fundamentals overall. Without profitability, this remains speculative—suitable only for those with high risk tolerance and a long time horizon.

Bull Case

The market underappreciates Bausch's consistent 436% ROE at just 13x earnings—a re-rating toward sector peers could unlock 30-50% upside. With $1.1 billion in annual free cash flow (51.7% yield), management has ample capital for buybacks, dividends, or accretive acquisitions.

Bear Case

Without a clear path to profitability, continued cash burn forces either dilutive equity raises or debt accumulation that destroys shareholder value. Regulatory changes, input cost inflation, or demand normalization represent underappreciated risks that could materially impact forward estimates.

Data from SEC filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer